Bio-Techne Corp. Stock
Bio-Techne Corp. Stock
The price for the Bio-Techne Corp. stock decreased slightly today. Compared to yesterday there is a change of -€0.200 (-0.450%).
With 22 Buy predictions and not a single Sell prediction Bio-Techne Corp. is an absolute favorite of our community.
With a target price of 60 € there is a positive potential of 35.14% for Bio-Techne Corp. compared to the current price of 44.4 €.
So far the community has only identified positive things for Bio-Techne Corp. stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".
Pros and Cons of Bio-Techne Corp. in the next few years
Pros
?
G***** c******* t* c**********
?
S********** s********
?
C******** o* t** e**********
Cons
?
W********* I********* f** t** n*** y****
?
B****
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Bio-Techne Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Bio-Techne Corp. | -0.450% | -4.721% | -12.079% | -22.783% | -11.200% | -35.652% | - |
| Haemonetics Corp. | -0.950% | -0.952% | 6.557% | - | -24.088% | - | - |
| Bio-Rad Labs Inc. A | 2.330% | 0.086% | 7.799% | -2.667% | -9.422% | -46.981% | -51.333% |
| Neogen Corp. | -3.730% | -10.405% | -14.365% | -8.824% | 26.016% | - | - |
Comments
Bio-Techne (TECH) had its "buy" rating reaffirmed by TD Cowen.
Show more
Ratings data for TECH provided by MarketBeat
Bio-Techne (NASDAQ:TECH) had its price target raised by analysts at Wells Fargo & Company from $70.00 to $76.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for TECH provided by MarketBeat
Bio-Techne (NASDAQ:TECH) had its "buy" rating reaffirmed by analysts at TD Cowen.
Show more
Ratings data for TECH provided by MarketBeat